This is a StreetInsider.com Premium Only Page

(ZNTL) – StreetInsider.com Reports

Apr 11, 2024 07:06 AM Zentalis Pharmaceuticals (ZNTL) Announces CFO Change

Feb 29, 2024 05:17 PM Zentalis Pharmaceuticals (ZNTL) Files Mixed Shelf

Jan 25, 2024 07:04 AM Zentalis Pharmaceuticals (ZNTL) Announces Management Changes

Jan 8, 2024 07:05 AM Immunome Inc. (IMNM) Exclusively Licenses Zentalis (ZNTL) ROR1 Antibody-Drug Conjugate

Nov 28, 2023 08:14 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $28 at UBS

Nov 8, 2023 06:48 AM Wedbush Downgrades Zentalis Pharmaceuticals (ZNTL) to Neutral

Nov 7, 2023 07:49 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $42 at Jefferies

Nov 7, 2023 07:16 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $36 at Stifel

Nov 7, 2023 06:20 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $46 at H.C. Wainwright

Nov 7, 2023 06:14 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $29 at Wells Fargo

Nov 7, 2023 06:07 AM Leerink Partners Downgrades Zentalis Pharmaceuticals (ZNTL) to Market Perform

Nov 6, 2023 07:34 AM Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q3 EPS by 13c

Aug 10, 2023 08:42 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $50 at Wells Fargo

Aug 9, 2023 09:17 AM Zentalis Pharmaceuticals, Inc. (ZNTL) Misses Q2 EPS by 82c

Aug 1, 2023 07:00 AM Zentalis Pharmaceuticals (ZNTL) Appoints Kimberly Freeman as Chief Strategy Officer

Jun 15, 2023 06:04 AM Zentalis Pharmaceuticals (ZNTL) Prices 11.03M Share Offering at $22.66/sh

Jun 7, 2023 07:51 AM Zentalis Pharmaceuticals (ZNTL) PT Raised to $50 at Stifel

Jun 7, 2023 07:26 AM Zentalis Pharmaceuticals (ZNTL) PT Raised to $51 at Wells Fargo

Jun 6, 2023 06:03 AM Zentalis Pharmaceuticals (ZNTL) Announces Intermittent Azenosertib Monotherapy Dosing Nearly Doubles Efficacy Over Continuous Dosing

May 26, 2023 07:28 AM Zentalis Pharmaceuticals (ZNTL) PT Raised to $38 at Wedbush

May 25, 2023 05:39 PM Zentalis Pharmaceuticals (ZNTL) Presentation of Positive Phase 1b Data Demonstrating Durable Responses and Favorable Safety Profile of Azenosertib in Combination with Chemotherapy

May 19, 2023 07:37 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $70 at Jefferies

May 11, 2023 07:44 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $45 at Stifel

Apr 17, 2023 09:03 AM Zentalis Pharmaceuticals (ZNTL) Announces Preclinical Data Supporting Cyclin E1 As A Predictive Marker For Azenosertib Treatment At AACR

Mar 15, 2023 07:53 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $46 at Stifel

Mar 2, 2023 09:27 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $55 at Stifel

Mar 1, 2023 08:08 AM Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q4 EPS by 19c

Feb 13, 2023 07:04 AM Zentalis Pharmaceuticals (ZNTL) Appoints Iris Roth as COO

Nov 18, 2022 09:29 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $52 at UBS

Nov 11, 2022 07:13 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $28 at Guggenheim

Nov 10, 2022 05:41 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $50 at Oppenheimer

Nov 9, 2022 03:22 PM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $58 at Stifel

Nov 9, 2022 07:44 AM Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q3 EPS by 26c

Oct 24, 2022 07:02 AM Zentalis Pharmaceuticals (ZNTL) Announces First ZN-c3 Clinical Development Collaboration with Pfizer (PFE)

Sep 27, 2022 04:01 PM Zentalis Pharmaceuticals (ZNTL) Promotes Co-Founder Kevin Bunker, Ph.D. to Chief Scientific Officer

Sep 19, 2022 07:03 AM Zentalis Pharmaceuticals (ZNTL) Appoints Carrie Brownstein as Chief Medical Officer

Sep 12, 2022 07:01 AM Zentalis Pharmaceuticals (ZNTL) Appoints Jan Skvarka to its Board

Aug 10, 2022 04:50 AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $80 at Oppenheimer

Jul 29, 2022 12:03 PM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $70 at Stifel, Keeps Buy with 'AstraZeneca Out Of The WEE1i Race'

Jul 12, 2022 05:30 AM UPDATE: Cowen Starts Zentalis Pharmaceuticals (ZNTL) at Outperform

Jun 27, 2022 07:11 AM Zentalis Pharmaceuticals (ZNTL) Names Andrea Paul as General Counsel as Alexis Pinto Resigns

May 31, 2022 07:07 AM Zentalis Pharmaceuticals (ZNTL) Promotes Cofounder Cam Gallagher to President

May 16, 2022 07:29 AM Zentalis Pharmaceuticals (ZNTL) Prices 10.33M Share Offering at $19.38/sh

May 16, 2022 07:02 AM Zentalis Pharmaceuticals (ZNTL) Appoints Kimberly Blackwell as CEO

May 5, 2022 04:05 PM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $72 at Stifel

Apr 27, 2022 09:07 AM Pre-Open Stock Movers 04/27: Mattel Up on Takeover Talk, Microsoft and Visa Gain on Earnings; NCR, Boeing, Google Drop Post Earnings (more...)

Apr 27, 2022 07:03 AM Zentalis Pharmaceuticals (ZNTL) Announces Pfizer (PFE) Acquired 953K Share Of the Company for $26.21/sh

Apr 12, 2022 04:27 AM Zentalis Pharmaceuticals (ZNTL) PT Raised to $100 at Oppenheimer

Apr 11, 2022 04:09 PM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $67 at SVB Leerink

Apr 11, 2022 04:02 PM Zentalis Pharmaceuticals (ZNTL) Overviews Clinical and Preclinical Data